What biomarkers are recommended for evaluating common autoimmune disorders?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18615276
Cited by: 0

Abstract

Biomarkers for autoimmune disorders span from traditional autoantibodies to promising new candidates like miRNAs; however, variations in specificity and responsiveness require cautious interpretation.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research T-cell and B-cell Immunology Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
10 February 2026
Language
EN